Influenza B NA Antibodies

Santa Cruz Biotechnology offers a broad range of Influenza B NA monoclonal antibodies for the detection and analysis of neuraminidase protein from Influenza B viruses. Influenza B NA Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Neuraminidase plays a crucial role in the life cycle of the Influenza B virus by facilitating the release of newly formed viral particles from infected cells, promoting viral spread and infection. Understanding neuraminidase function is essential for developing effective antiviral therapies and vaccines, as well as for studying viral pathogenesis and epidemiology. Researchers can utilize Influenza B NA monoclonal antibodies to investigate viral entry mechanisms and host-pathogen interactions. Characterization of Influenza B NA enables detailed analysis of viral protein expression patterns and cellular localization. Advanced research techniques incorporating Influenza B NA monoclonal antibodies support viral mutation tracking and strain identification. Santa Cruz Biotechnology monoclonal antibodies for Influenza B NA support scientific advancement in viral research and contribute to improved public health outcomes.